CDH2 and breast carcinoma: In this study, we utilized the biosynthetic GVs to deliver the plasmid containing sgRNA targeting the exon3 of the Cdh2 gene to Cas9-stably expressed 4T1 breast cancer cells via ultrasound-mediated bubble cavitation, followed by functional verification of the inhibition in tumor invasion and metastasis (Figure 1).